Pat PurcellMeeting Engagement
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Paul TheisenPatient Acquisition
Matt TurnerPatient Affordability
Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Suma Ramadas, PhDMedical Affairs
ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...
- Acquisition adds Zavante’s CONTEPO™, potential first-in-class in the United States injectable antibiotic for ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email